The effect of an rhBMP-2 absorbable collagen sponge-targeted system on bone formation in vivo

Biomaterials

Volumn 30, Issue 11, 2009, Pages 2032-2037

  Visser, Rick ^a,b   Arrabal, Pilar M ^a,b   Becerra, Jose ^a,b   Rinas, Ursula ^c   Cifuentes, Manuel ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

BMP (bone morphogenetic protein); Bone tissue engineering; Collagen; Osteogenesis; Recombinant protein

Indexed keywords

AUTOLOGOUS BONE GRAFTING; BMP (BONE MORPHOGENETIC PROTEIN); BONE DEFECTS; BONE DISEASE; BONE FORMATIONS; BONE GRAFTS; BONE REPAIRS; BONE TISSUE ENGINEERING; COLLAGEN SPONGES; ECONOMIC CONCERNS; ECTOPIC BONES; FUSION PROTEINS; IN-VIVO; IN-VIVO EXPERIMENTS; OSTEOGENESIS; RECOMBINANT PROTEIN; RHBMP-2; VON WILLEBRAND FACTORS;

BIOMATERIALS; COLLAGEN; HYDROXYAPATITE; PROTEINS; TISSUE ENGINEERING;

BONE;

AMINO TERMINAL TELOPEPTIDE; COLLAGEN SPONGE; COLLAGEN TYPE 1; HYDROXYAPATITE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; VON WILLEBRAND FACTOR;

ANIMAL CELL; ARTICLE; BIODEGRADABLE IMPLANT; BONE DEVELOPMENT; BONE REMODELING; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; COLLAGEN; HUMANS; MICE; OSTEOGENESIS; RECOMBINANT PROTEINS;

EID: 59849120814     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.12.046     Document Type: Article

References (37)

1. Hogan B.L. Bone morphogenetic proteins in development. Curr Opin Genet Dev 6 4 (1996) 432-438
2. Nakase T., and Yoshikawa H. Potential roles of bone morphogenetic proteins (BMPs) in skeletal repair and regeneration. J Bone Miner Metab 24 6 (2006) 425-433
3. Wang E.A., Rosen V., D'Alessandro J.S., Bauduy M., Cordes P., Harada T., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 87 6 (1990) 2220-2224
4. Volek-Smith H., and Urist M.R. Recombinant human bone morphogenetic protein (rhBMP) induced heterotopic bone development in vivo and in vitro. Proc Soc Exp Biol Med 211 3 (1996) 265-272
5. Kneser U., Schaefer D.J., Polykandriotis E., and Horch R.E. Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med 10 1 (2006) 7-19
6. Takaoka K., Nakahara H., Yoshikawa H., Masuhara K., Tsuda T., and Ono K. Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clin Orthop Relat Res 234 (1988) 250-254
7. Lewandrowski K.U., Gresser J.D., Wise D.L., and Trantol D.J. Bioresorbable bone graft substitutes of different osteoconductivities: a histologic evaluation of osteointegration of poly(propylene glycol-co-fumaric acid)-based cement implants in rats. Biomaterials 21 8 (2000) 757-764
8. Bucholz R.W. Nonallograft osteoconductive bone graft substitutes. Clin Orthop Relat Res 395 (2002) 44-52
9. Rush S.M. Bone graft substitutes: osteobiologics. Clin Podiatr Med Surg 22 4 (2005) 619-630
10. Minamide A., Yoshida M., Kawakami M., Yamasaki S., Kojima H., Hashizume H., et al. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion. Spine 30 10 (2005) 1134-1138
11. Lindholm T.S., and Gao T.J. Functional carriers for bone morphogenetic proteins. Ann Chir Gynaecol Suppl 207 (1993) 3-12
12. Bessa P.C., Casal M., and Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2 2-3 (2008) 81-96
13. Peel S.A., Hu Z.M., and Clokie C.M. In search of the ideal bone morphogenetic protein delivery system: in vitro studies on demineralized bone matrix, purified, and recombinant bone morphogenetic protein. J Craniofac Surg 14 3 (2003) 284-291
14. Blum B., Moseley J., Miller L., Richelsoph K., and Haggard W. Measurement of bone morphogenetic proteins and other growth factors in demineralized bone matrix. Orthopedics 27 Suppl. 1 (2004) 161-165
15. Kale A.A., and Di Cesare P.E. Osteoinductive agents. Basic science and clinical applications. Am J Orthop 24 10 (1995) 752-761
16. Hartman E.H., Pikkemaat J.A., Van Asten J.J., Vehof J.W., Heerschap A., Oyen W.J., et al. Demineralized bone matrix-induced ectopic bone formation in rats: in vivo study with follow-up by magnetic resonance imaging, magnetic resonance angiography, and dual-energy X-ray absorptiometry. Tissue Eng 10 5-6 (2004) 747-754
17. Behnam K., Murray S.S., and Brochmann E.J. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix. Connect Tissue Res 47 5 (2006) 271-277
18. Geiger M., Li R.H., and Friess W. Collagen sponges for bone regeneration with rh-BMP2. Adv Drug Deliv Rev 55 12 (2003) 1613-1629
19. Swiontkowski M.F., Aro H.T., Donell S., Esterhai J.L., Goulet J., Jones A., et al. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am 88 6 (2006) 1258-1265
20. Itoh K., Udagawa N., Katagiri T., Iemura S., Ueno N., Yasuda H., et al. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappa B ligand. Endocrinology 142 8 (2001) 3656-3662
21. Sciadini M.F., and Johnson K.D. Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model. J Orthop Res 18 2 (2000) 289-302
22. Nishi N., Matsushita O., Yuube K., Miyanaka H., Okabe A., and Wada F. Collagen-binding growth factors: production and characterization of functional fusion proteins having a collagen-binding domain. Proc Natl Acad Sci U S A 95 12 (1998) 7018-7023
23. Kitajima T., Terai H., and Ito Y. A fusion protein of hepatocyte growth factor for immobilization to collagen. Biomaterials 28 (2007) 1989-1997
24. Ishikawa T., Eguchi M., Wada M., Iwami Y., Tono K., Iwaguro H., et al. Establishment of a functionally active collagen-binding vascular endothelial growth factor fusion protein in situ. Arterioscler Thromb Vasc Biol 26 9 (2006) 1998-2004
25. Takagi J., Asai H., and Saito Y. A collagen/gelatin-binding decapeptide derived from bovine propolypeptide of von Willebrand factor. Biochemistry 31 (1992) 8530-8534
26. Tuan T.L., Cheung D.T., Wu L.T., Yee A., Gabriel S., Han B., et al. Engineering, expression and renaturation of targeted TGF-beta fusion proteins. Connect Tissue Res 34 (1996) 1-9
27. Hall F.L., Kaiser A., Liu L., Chen Z.H., Hu J., Nimni M.E., et al. Design, expression, and renaturation of a lesion-targeted recombinant epidermal growth factor-von Willebrand factor fusion protein: efficacy in an animal model of experimental colitis. Int J Mol Med 6 (2000) 635-643
28. Andrades J.A., Wu L.T., Hall F.L., Nimni M.E., and Becerra J. Engineering, expression, and renaturation of a collagen-targeted human bFGF fusion protein. Growth Factors 18 (2001) 261-275
29. Han B., Perelman N., Tang B., Hall F., Shors E.C., and Nimni M.E. Collagen-targeted BMP3 fusion proteins arrayed on collagen matrices or porous ceramics impregnated with type I collagen enhance osteogenesis in a rat cranial defect model. J Orthop Res 20 (2002) 747-755
30. Anderson H.C., Hsu H.H., Raval P., Hunt T.R., Schwappach J.R., Morris D.C., et al. The mechanism of bone induction and bone healing by human osteosarcoma cell extracts. Clin Orthop Relat Res 313 (1995) 129-134
31. Vallejo L.F., Brokelmann M., Marten S., Trappe S., Cabrera-Crespo J., Hoffmann A., et al. Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. J Biotechnol 94 (2002) 185-194
32. Vallejo L.F., and Rinas U. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration. Biotechnol Bioeng 85 (2004) 601-609
33. Govender S., Csimma C., Genant H.K., Valentin-Opran A., Amit Y., Arbel R., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A 12 (2002) 2123-2134
34. Han B., Hall F.L., and Nimni M.E. Refolding of a recombinant collagen-targeted TGF-beta 2 fusion protein expressed in Escherichia coli. Protein Expr Purif 11 2 (1997) 169-178
35. Chen B., Lin H., Zhao Y., Wang B., Zhao Y., Liu Y., et al. Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide. J Biomed Mater Res A 80 2 (2007) 428-434
36. Chen B., Lin H., Wang J., Zhao Y., Wang B., Zhao W., et al. Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials 28 6 (2007) 1027-1035
37. Ishikawa T., Terai H., and Kitajima T. Production of a biologically active epidermal growth factor fusion protein with high collagen affinity. J Biochem 129 4 (2001) 627-633